Apixaban is becoming more frequently prescribed for stroke prevention in patients with atrial fibrillation, and even rare side effects such as thrombocytopenia should be considered and monitored closely.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935631 | PMC |
http://dx.doi.org/10.1002/ccr3.2532 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!